Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/03/2012CN102703388A Anti-human mCRP (monomeric C-reaction protein) monoclonal antibody, hybridoma cell lines and kit
10/03/2012CN102703369A Recombinant bifidobacterium for preparing EV (Enterovirus) 71 vaccine as well as preparation method and application of recombinant bifidobacterium
10/03/2012CN102702359A Identification of novel igE epitopes
10/03/2012CN102702358A Antibody against the CSF-1 R
10/03/2012CN102702355A Anti FGF23 antibody and a pharmaceutical composition comprising the same
10/03/2012CN102702353A Anti-glypican 3 antibody
10/03/2012CN102702352A Human anti-EV71 virus neutralization antibody EV71FabL4 and preparation method and application thereof
10/03/2012CN102702351A Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof
10/03/2012CN102702348A Monoclonal antibodies against Enterovirus 71 and uses thereof
10/03/2012CN102698291A Brucella antigen gene combination ROB capable of improving cellullar immunologic response
10/03/2012CN102698288A Bacterially-delivered non-injective DNA vaccine
10/03/2012CN102698270A Method for enhancing therapeutic agent uptake by target cell and pharmaceutical composition
10/03/2012CN102698267A Adjuvant therapy with the use of anti-glypican 3 antibody
10/03/2012CN102698266A Application of CD200 for preparing systemic lupus erythematosus psychotherapeutic drugs
10/03/2012CN102698265A Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
10/03/2012CN102698264A Bursin-like polypeptide derivative applied as immuno-enhancer of compound hog cholera vaccines
10/03/2012CN102698263A Multivalent pcv2 immunogenic compositions and methods of producing such compositions
10/03/2012CN102698262A Method for producing triple inactivated vaccines for new castle disease, egg drop syndrome and avian viral arthritis
10/03/2012CN102698261A Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
10/03/2012CN102698260A Preparation method and application of subunit vaccine for preventing Staphylococcus-induced mammitis of goats
10/03/2012CN102698259A Preparation method for necrotic enteritis (Type A) inactivated vaccine
10/03/2012CN102698258A Composition and method for the treatment and prevention of enteric bacterial infections
10/03/2012CN102697812A Method for extracting exosome from chicken bile and application of exosome in immunology
10/03/2012CN102697733A Polylactic acid-glycolic acid co-polymer nanometer granule internally wrapping toxin and externally connected with antibody
10/03/2012CN102697705A Liposome gel preparation and preparation method and application thereof
10/03/2012CN102154366B Swine influenza virus H3N2 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
10/03/2012CN101899461B Fusion gene capable of encoding influenza A virus NP protein and M2e polypeptide
10/03/2012CN101890162B New use of PEG-PCL-PEG (polyethylene glycol-polycaprolactone-polyethylene glycol) and antigen-assembled mixture
10/03/2012CN101851609B Porcine parvovirus L strain and use thereof in preparation of porcine parvovirus inactivated vaccines
10/03/2012CN101812473B Human papillomavirus and chlamydia trachomatis chimeric nucleic acid vaccine and applications thereof
10/03/2012CN101568647B Secretion of antibodies without signal peptides from bacteria
10/03/2012CN101563366B Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
10/03/2012CN101505792B Tumor therapy with an anti-VEGF antibody
10/03/2012CN101365481B Canine influenza virus and related compositions and methods of use
10/03/2012CN101291693B Novel use of il-1beta compounds
10/03/2012CN101284874B Peptide-based immunization therapy for treatment of atherosclerosis
10/03/2012CN101180313B Fermentation process for the production of diphtheria toxin
10/03/2012CN101011574B Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
10/02/2012US8278433 Methods and compositions for expressing negative-sense viral RNA in canine cells
10/02/2012US8278423 Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)
10/02/2012US8278421 Human antibodies specific for gastrin materials and methods
10/02/2012US8278412 Polypeptide, nucleic acid molecule encoding it and their uses
10/02/2012US8278286 Use of gp130 activators in diabetic neuropathy
10/02/2012US8278278 Cell proliferation reducing cancer specific PCNA peptides
10/02/2012US8278093 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
10/02/2012US8278083 Inactivated influenza virus compositions
10/02/2012US8278056 Detection of early stages and late stages HPV infection
10/02/2012US8278042 Compositions and methods for the diagnosis and treatment of tumor
10/02/2012US8277835 Nutritional composition comprising immunoglobulins and oligosaccharides
10/02/2012US8277822 Botulinum toxin treatment
10/02/2012US8277821 Immunizing compositions and methods of use
10/02/2012US8277820 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli
10/02/2012US8277819 Norovirus particle for use as an antiviral or vaccine
10/02/2012US8277818 Herpes virus strains for gene therapy
10/02/2012US8277816 Bacillus anthracis antigens, vaccine compositions, and related methods
10/02/2012US8277815 Pharmaceutical composition comprising an antigen
10/02/2012US8277814 Avian Astrovirus
10/02/2012US8277813 Tick salivary polypeptide for use in generating vaccine for prevention and treatment of blood borne infection; immunotherapy
10/02/2012US8277812 Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
10/02/2012US8277811 Compositions and methods for inducing chimerism in a subject
10/02/2012US8277810 Antagonist anti-CD40 antibodies
10/02/2012US8277809 CXCL13 antagonists and their use for the treatment of inflammatory diseases
10/02/2012US8277808 Mucosal vascular addressins and uses thereof
10/02/2012US8277807 Pharmaceutical combinations
10/02/2012US8277806 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
10/02/2012US8277805 Methods for treating or inhibiting thromboembolic disorders or for inhibiting coagulation
10/02/2012US8277804 Antagonists of IL-6 to prevent or treat thrombosis
10/02/2012US8277803 Cancerous disease modifying antibodies
10/02/2012US8277802 Diagnosis and prevention of cancer cell invasion
10/02/2012US8277797 Interferon-β production modulating Listeria strains and methods for using same
10/02/2012US8277792 Peptides for active anti-cytokine immunization
10/02/2012US8277778 Vaccine adjuvants
10/02/2012CA2552266C Continuous method for producing bioactive molecule coated particles, bioactive molecule coated particles and uses therefor
10/02/2012CA2530038C Vaccines comprising polynucleotides
10/02/2012CA2494223C Campylobacter glycans and glycopeptides
10/02/2012CA2492883C Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/02/2012CA2465895C Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
10/02/2012CA2452841C Method of sporulating eimeria oocytes
10/02/2012CA2430135C Recombinant anti-cd30 antibodies and uses thereof
10/02/2012CA2417874C Use of ox-2 inhibitors for the treatment of cancer
10/02/2012CA2412497C Vaccine composition
10/02/2012CA2402268C Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
10/02/2012CA2396534C Intrabodies with defined framework that is stable in a reducing environment and applications thereof
10/02/2012CA2332733C Signal peptides, nucleic acid molecules and methods for treatment of caries
10/02/2012CA2311297C Erythrovirus and its applications
10/02/2012CA2309003C Insect cells or fractions as adjuvant for antigens
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
09/2012
09/27/2012WO2012129520A1 Tcr mimic antibodies as vascular targeting tools
09/27/2012WO2012129483A1 Adjuvant nanoemulsions with phospholipids
09/27/2012WO2012129448A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins
09/27/2012WO2012129375A2 Vaccination of sex reversed hybrid tilapia (oreochromis niloticus x o. aureus) with an inactivated vibrio vulnificus vaccine
09/27/2012WO2012129335A2 Hyd1 peptides for relapsed cancer
09/27/2012WO2012129330A1 Targeted cytokine for treatment of musculoskeletal diseases
09/27/2012WO2012129295A1 Rapid and prolonged immunologic-therapeutic
09/27/2012WO2012129227A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
09/27/2012WO2012128628A1 Immunogenic compositions in particulate form and methods for producing the same
09/27/2012WO2012128508A2 Binding molecules capable of neutralizing the rabies virus, and uses thereof
09/27/2012WO2012128377A1 Composition for treatment and diagnosis of pancreatic cancer
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1823